ARTICLE | Clinical News
Zelboraf vemurafenib regulatory update
December 23, 2013 8:00 AM UTC
Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said in a planned reassessment that Zelboraf vemurafenib from Roche for melanoma has "significant" additional benefit vs. dacarbazi...